Vitrafy Life Sciences Ltd (ASX:VFY – Get Free Report) insider John McBain acquired 28,255 shares of the business’s stock in a transaction that occurred on Tuesday, March 18th. The shares were acquired at an average cost of A$1.36 ($0.87) per share, with a total value of A$38,426.80 ($24,475.67).
Vitrafy Life Sciences Stock Performance
Read More
- Five stocks we like better than Vitrafy Life Sciences
- High Flyers: 3 Natural Gas Stocks for March 2022
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- How Investors Can Find the Best Cheap Dividend Stocks
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Ride Out The Recession With These Dividend Kings
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Vitrafy Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitrafy Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
